These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9493574)
1. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia. Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574 [TBL] [Abstract][Full Text] [Related]
2. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110 [TBL] [Abstract][Full Text] [Related]
3. In vivo platelet activity and lipoprotein patterns in coronary artery disease. Goubran F; Maklady F; Saad M; el-Ashry M Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598 [TBL] [Abstract][Full Text] [Related]
4. Platelet function in hyperlipoproteinaemia. Parízek M; Parízková M; Kubisz P Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):752-9. PubMed ID: 2416652 [TBL] [Abstract][Full Text] [Related]
5. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease. Ravindran R; Krishnan LK Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614 [TBL] [Abstract][Full Text] [Related]
6. Kinetics and in vivo distribution of in-111-labelled platelets and platelet function in familial hypercholesterolaemia. Wessels P; Heyns AD; Esterhuysen AJ; Badenhorst PN; Lötter MG; Pieters H; Kotzè HF Thromb Haemost; 1987 Oct; 58(3):811-6. PubMed ID: 3433247 [TBL] [Abstract][Full Text] [Related]
7. The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia. Saklamaz A; Comlekci A; Temiz A; Caliskan S; Ceylan C; Alacacioglu A; Yesil S Metabolism; 2005 May; 54(5):677-81. PubMed ID: 15877299 [TBL] [Abstract][Full Text] [Related]
8. Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Koga H; Sugiyama S; Kugiyama K; Fukushima H; Watanabe K; Sakamoto T; Yoshimura M; Jinnouchi H; Ogawa H Eur Heart J; 2006 Apr; 27(7):817-23. PubMed ID: 16434416 [TBL] [Abstract][Full Text] [Related]
9. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis]. Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results. Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375 [TBL] [Abstract][Full Text] [Related]
11. Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers. Albert J; Wall n NH; Li N; Frostell C; Hjemdahl P Clin Sci (Lond); 1999 Sep; 97(3):345-53. PubMed ID: 10464060 [TBL] [Abstract][Full Text] [Related]
12. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
13. [Platelet aggregation in hyperlipoproteinemias]. Calabrese S; Da Col PG; Giansante C; Morgante O; Cattin L Minerva Med; 1982 May; 73(22):1541-6. PubMed ID: 7088380 [TBL] [Abstract][Full Text] [Related]
15. Increased platelet activity in patients with isolated coronary artery ectasia. Yasar AS; Erbay AR; Ayaz S; Turhan H; Metin F; Ilkay E; Sabah I Coron Artery Dis; 2007 Sep; 18(6):451-4. PubMed ID: 17700216 [TBL] [Abstract][Full Text] [Related]
16. Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia. Davì G; Ganci A; Averna M; Giammarresi C; Barbagallo C; Catalano I; Calà A; Notarbartolo A Thromb Haemost; 1995 Oct; 74(4):1015-9. PubMed ID: 8560403 [TBL] [Abstract][Full Text] [Related]
17. Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Wallén NH; Goodall AH; Li N; Hjemdahl P Clin Sci (Lond); 1999 Jul; 97(1):27-35. PubMed ID: 10369791 [TBL] [Abstract][Full Text] [Related]
18. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry. Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185 [TBL] [Abstract][Full Text] [Related]
19. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179 [TBL] [Abstract][Full Text] [Related]